• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL Back to Search Results
Model Number BXA077902A
Device Problems Partial Blockage (1065); Obstruction of Flow (2423)
Patient Problems Stenosis (2263); Obstruction/Occlusion (2422)
Event Date 06/14/2022
Event Type  Injury  
Manufacturer Narrative
Cbas® heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.A review of the manufacturing records for lot #'s 23452104 and 23452090 indicated the lots met pre-release manufacturing specifications.Due to no device return, an investigation could not be performed.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
The following information was received by gore from the medrio database in regards to tambe clinical study aaa 17-01: on (b)(6) 2021, a patient received treatment for a thoracoabdominal aortic aneurysm with the gore® viabahn® vbx balloon expandable endoprosthesis being implanted within the right renal artery.On (b)(6) 2022, occlusion was observed within the gore® viabahn® vbx balloon expandable endoprosthesis located in the right renal artery.No treatment has been rendered.
 
Event Description
On (b)(6), 2021, a study patient received treatment for a thoracoabdominal aortic aneurysm.During this procedure, two gore® viabahn® vbx balloon expandable endoprosthesis (vbx device) were overlapped and implanted within the right renal artery.On (b)(6) 2022, stenosis was observed within the vbx device located in the right renal artery.No intervention was performed.Additional information obtained on september 27, 2022, states there is some intraluminal thrombus present at the distal end of the second right renal artery.No intervention was reported; right renal component was reported as remaining patent.
 
Manufacturer Narrative
A4 - patient weight was added.B3 - event date was corrected to onset date.B4 - event description was updated with new information.B7 - added patient medical history, including medication.Contact name was updated in section g.H6 codes were updated.
 
Event Description
On (b)(6) 2021, a patient received treatment for a thoracoabdominal aortic aneurysm.During this procedure, two gore® viabahn® vbx balloon expandable endoprosthesis (vbx device) were overlapped and implanted within the right renal artery.One vbx device was implanted in the first distal extension ((b)(6); bxa077902a) and the second vbx device was implanted in the most proximal within the portal ((b)(6); bxa077902a).On (b)(6) 2022, stenosis was observed within the vbx device located in the right renal artery.No intervention was reported at the time.Additional information obtained on september 27, 2022: some intraluminal thrombus is present at the distal end of the second right renal artery.No intervention was reported at the time.It was stated the right renal sb component remained patent.Additional information obtained on october 11, 2022: on (b)(6) 2022, an intervention was performed due to stent graft stenosis.Angioplasty and stenting were done.Reintervention on the treated segment reintervention was performed before occlusion to prevent eventual loss of patency.
 
Manufacturer Narrative
B3 - event description was updated with new information.Patient had an intervention performed due to.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS
Type of Device
ILIAC COVERED STENT, ARTERIAL
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
genevieve begay
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key15266535
MDR Text Key298319519
Report Number2017233-2022-03252
Device Sequence Number1
Product Code PRL
UDI-Device Identifier00733132637539
UDI-Public00733132637539
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P160021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 10/11/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/22/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/13/2024
Device Model NumberBXA077902A
Device Catalogue NumberBXA077902A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/11/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/14/2021
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
Patient Age81 YR
Patient SexMale
Patient Weight71 KG
Patient EthnicityNon Hispanic
Patient RaceBlack Or African American
-
-